Class II · Moderate risk
Hydrochlorothiazide Tablet USP 25 mg
Presence of Foreign Tablet: A pharmacist found a clopidogrel tablet in the 1000-count bottle of hydrochlorothiazide 25 mg tablets.
FDA Drug Recalls
1,464 recalls · Class II, newest first
Class II · Moderate risk
Lisinopril Tablets
Failed Dissolution Specifications
Class II · Moderate risk
Lisinopril Tablets USP
CGMP Deviations: An FDA inspection identified inadequate investigations of past market complaints.
Class II · Moderate risk
Lisinopril Tablets USP
CGMP Deviations: An FDA inspection identified inadequate investigations of past market complaints.
Class II · Moderate risk
Daytrana (methylphenidate transdermal system)
Defective Delivery System: Out of specification for z-statistic related to mechanical peel force.
Class II · Moderate risk
univasc (moexipril HCl)
Failed Dissolution Testing: Failed 24 month dissolution testing.
Class II · Moderate risk
Combivent Respimat
Defective Delivery System: Inhalers do not spray properly, emitting either no spray or a short transient spray.
Class II · Moderate risk
Vitamin D3 Oil
Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
Class II · Moderate risk
Vitamin D3 Oil
Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
Class II · Moderate risk
Vitamin B-Complex
Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
Class II · Moderate risk
Trimix
Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
Class II · Moderate risk
Trimix
Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
Class II · Moderate risk
Trimix
Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
Class II · Moderate risk
Trimix
Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
Class II · Moderate risk
Trimix
Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
Class II · Moderate risk
Trimix
Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
Class II · Moderate risk
Testosterone/Anastrozole
Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
Class II · Moderate risk
Testosterone/Anastrozole
Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
Class II · Moderate risk
Testosterone Proprionate
Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
Class II · Moderate risk
Testosterone Cypionate for Subq Injection
Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
Class II · Moderate risk
Testosterone Cypionate for Subq Injection
Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
Class II · Moderate risk
Testosterone Cypionate
Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
Class II · Moderate risk
Testosterone
Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
Class II · Moderate risk
Testosterone
Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
Class II · Moderate risk
Testosterone
Lack of Assurance of Sterility; all sterile human compounded drugs within expiry